Product Information
PRASUGREL 5 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.2616 per EA under NDC 65162000103. Its NADAC has been published 413 times since Oct 10, 2018.
FDA first approved this application on Jun 19, 2018.
Strength
5 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162000103
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PRASUGREL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205913FDA Approved
6/19/2018
On Market Since
6/22/2018
Pharmacological Classes
Price Statistics
The NADAC for PRASUGREL 5 MG TABLET has been published 413 times since Oct 10, 2018, and over the history we have for it it has declined 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2616 per EA |
|---|---|
| All-time high | $0.6953 (Apr 15, 2020) |
| All-time low | $0.2539 (May 22, 2024) |
| 52-week high | $0.3519 |
| 52-week low | $0.2606 |
| Median price | $0.4038 |
| Average price | $0.4161 |
| Largest weekly change | +60.6% (Feb 21, 2024) |
| Weeks tracked | 413 |
| Tracking since | Oct 10, 2018 |
1W
N/A
1M
N/A
3M
-8.5%
6M
-9.6%
1Y
-25.2%
3Y
-31.6%
5Y
-42.2%
All
-53.3%
Last surveyed Sep 2, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prasugrel market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
P2Y12 Platelet Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRASUGREL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRASUGREL 5 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.2616 per EA (NDC 65162000103), effective Sep 2, 2026.
How has the price of PRASUGREL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRASUGREL 5 MG TABLET has declined 53.3%. It has been tracked across 413 weekly CMS publications since Oct 10, 2018.
What are the highest and lowest recorded NADAC prices for PRASUGREL 5 MG TABLET?
Since Oct 10, 2018, the NADAC for PRASUGREL 5 MG TABLET has ranged from a low of $0.2539 (May 22, 2024) to a high of $0.6953 (Apr 15, 2020), with a median of $0.4038 per EA.
Are there cheaper alternatives to PRASUGREL 5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PRASUGREL 5 MG TABLET, is $0.2592 per EA — about 1% below PRASUGREL 5 MG TABLET.
Who manufactures PRASUGREL 5 MG TABLET?
PRASUGREL 5 MG TABLET (NDC 65162000103) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.